MyoMed Launches Flash Virtual Tour of Toxin-Free P... (d isrecommended by doctors and athletes ...)

MyoMed Launches Flash Virtual Tour of Toxin-Free Pain Relief

Date:10/9/2007

d is recommended by doctors and athletes for all those who refuse to let sore muscles, arthritis, or backache get in the way of living. MyoMed provides pain relief through all-natural, toxin-free ingredients such as CFAs, Bryonia Alba, Rhus Toxicodendron, shark-liver oil and deodorized garlic oil (contains no methyl salicylate, trolamine salicylate, alcohol, dyes or paraben). MyoMed's proprietary, all-natural nano delivery system carries pain-relieving and anti-inflammatory ingredients deep into affected tissue to provide fast and lasting relief. It has been used as a therapeutic treatment by those suffering such pain-causing ailments as arthritis, sports injuries, backache, strains, bruises and sprains. BioForce is a privately held company based in Utah.

SOURCE BioForce
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms

Post Your Comments:

(Date:12/6/2009)... ORLEANS, Dec. 6 Sickle cell disease, ... blood cells, is one of the most common ... the world, including more than 70,000 Americans.(1) Research ... the American Society of Hematology highlights intriguing studies ... presents for children with this blood disorder, evaluations ...

(Date:12/6/2009)... Dec. 6, 2009 A new study provides welcome ... as venous thromboembolism (VTE). , The condition is ... year, and occurs when an abnormal clot forms in ... pain and swelling. In some cases, the clot may ... the heart to the lungs, causing a potentially fatal ...

(Date:12/6/2009)... Volunteer organizations and members of the community, in cooperation with the ... create a holiday party. This year,s attendance is expected to soar ... , ... (PRWEB) December 6, 2009 -- ... Greater VA Healthcare System in West Los Angeles, will once again ...

(Date:12/5/2009)... a phase 1/2 clinical trial that it is ... newly diagnosed with multiple myeloma, a cancer of white ... Cancer Institute. , Partial responses or better were seen ... drug combination in the multi-center study, with 74 percent ... phase 2 population, reports Paul G. Richardson, MD, of ...

(Date:12/5/2009)... Cuts for a Cause ,, Why: ... other terminal illnesses affecting children. All proceeds from each hair ... Hospital. Guests will enjoy complimentary beverages and hors d,oeuvres, provided ... Falls Church for all guests. Hoa Lai, a DJ known ...

[0] Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease [0] New drug shows promise for those with clotting disorders: McMaster researcher [0] 17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” [0] Multiple myeloma patients experience high response rate with new 3-drug combination [0] Salon Leau to Host 'Cuts for a Cause' to Raise Funds and Spread the Word About Childhood Terminal Illnesses

... to Reduce Disparities in Meningococcal Vaccination; Increase Educational Efforts ... Dec. 2 The National Foundation for ... Protect.) Meningitis! coalition, composed of many of ... a Call to Action to improve adolescent meningococcal vaccination ...

... safe, research shows , , TUESDAY, Dec. 2 (HealthDay News) -- ... more prone to error than if they were speaking with ... new report finds. , "We think it is basically a ... sitting next to you who is experienced as a driver, ...

... Focus-- , , ... of breakthrough nanoscale platforms for molecular diagnostics, personalized ... of Gary Zweiger, Ph.D., as vice president of ... decade of strategic business development experience with leading ...

... Neuralstem Inc.,(NYSE Alternext US: CUR) announced today that ... University & Hospital of Taiwan, to,advance development of Neuralstem,s ... will focus on Amyotrophic Lateral Sclerosis (ALS,or Lou Gehrig,s ... , (Logo: ...

... Dec. 2 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical,Inc. ... CSKI ), a leading,fully integrated pharmaceutical ... China ("PRC"), announced today that Mr. Yu-bo,(Stanley) Hao ... will,also serve on the Company,s Board of Directors. ...

... MYL ) today,announced that it and its subsidiary, ... Novartis Pharmaceuticals Corp., Novartis,Corp. and Novartis International AG related ... Mylan,s Vice Chairman ... to have reached this agreement, which demonstrates our ability ...

Other Medicine News:Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2 Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3 Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4 Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 2 Health News:Car Cell Phone Use More Hazardous Than Chat With Passengers 3 Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 2 Health News:BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development 3 Health News:Neuralstem Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials 2 Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 2 Health News:China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO 3 Health News:Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity 2

NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis Car Cell Phone Use More Hazardous Than Chat With Passengers BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development Neuralstem Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials China Sky One Medical, Inc. Appoints Yu-bo Hao as CFO Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity

(Date:12/4/2009)... Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on ... Reorganization and related amended Disclosure Statement with the United States ... A hearing to consider the adequacy of the Disclosure Statement ... on the confirmation of the Plan scheduled for January 7, ...

(Date:12/4/2009)... (Nasdaq: ONXX ) today announced that it will ... will discuss the data presentations surrounding carfilzomib in relapsed ... American Society of Hematology (ASH) Annual Meeting. ,, The ... on Monday, December 7, 2009. The live webcast ...

(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...

Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2 Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3 Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2 Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2 Record Number of New Medicines in Development for Women 6212 1 Record Number of New Medicines in Development for Women 6212 2 Gene Therapy Brings New Muscle to Monkeys 61251 1 Coffee break 3A Compound brewing new research in colon breast cancer 61247 1 Coffee break 3A Compound brewing new research in colon breast cancer 61247 2 Coffee break 3A Compound brewing new research in colon breast cancer 61247 3 Coffee break 3A Compound brewing new research in colon breast cancer 61247 4 Coffee break 3A Compound brewing new research in colon breast cancer 61247 5 Coffee break 3A Compound brewing new research in colon breast cancer 61247 6

[0] Vermillion Files Amended Plan of Reorganization and Exchanges Debt [0] Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference [0] Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care

... 9 Surgeons are testing new,ways of treating ... this country,-- massive bleeding. Investigators from Massachusetts General ... prolong the time surgeons,have to correct bleeding problems ... the surgical researchers found that profound hypothermia,effectively treated ...

... 9 In an effort to increase,access and ... The Leukemia & Lymphoma Society and Cleveland Clinic ... Clinical,Trial Center for Hematologic Malignancies. This innovativecollaboration ... trials available to patients in their community so ...

Other Medicine Technology:Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 2 Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 3 Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 4 Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 5 The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals 2 The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals 3 The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals 4

Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals

... is recommended for separations of DNA fragments ... that are easy to handle, and remains ... minimizes the risk of cracking or breaking. ... (GQT) products with similar sieving properties, is ...

... Agarose-HR™ High Resolution - ... from 50 to 1000 ... for sizing PCR fragments, ... by restriction enzyme digestion, ...

The reading of agglutinations process in Diana Reader is by image treatment which allows great sensitivity....

... designed for medium to ... centers and reference laboratories ... antibody screening. It will ... functions including blood group ...

Medicine Products:

Certified PCR Agarose Agarose-HR™Diana Reader TANGO Benchtop Blood Bank Analyzer

MyoMed Launches Flash Virtual Tour of Toxin-Free P...(d isrecommended by doctors and athletes ...),Health